Cytomegalovirus in severe colitis: diagnostic pitfalls and a pragmatic testing framework
Frontiers in Cellular and Infection Microbiology · 05.11.2026 · 16
DOI: 10.3389/fcimb.2026.1813808 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 05.11.2026. Verfasst von Mohammed Adnan Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Darlington Memorial Hospital, County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Cytomegalovirus, Colitis, Colitis, Ulcerative. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cytomegalovirus (CMV) is an important complication of severe colitis, particularly in patients with ulcerative colitis (UC), corticosteroid-refractory disease, and significant immunosuppression. However, clinically relevant CMV involvement may also occur in patients without conventional immunosuppressive risk factors, whilst CMV may be detected as secondary or low-level reactivation in severely inflamed mucosa. Distinguishing clinically significant CMV-associated disease from incidental viral detection remains a diagnostic challenge. Clinical and endoscopic features are insufficiently specific, and interpretation is complicated by differences in the sensitivity, specificity, and clinical meaning of diagnostic tests. This Mini Review examines the roles and limitations of histology, immunohistochemistry (IHC), tissue polymerase chain reaction (PCR), and blood CMV PCR in adults presenting with severe colitis. Attention is given to mucosal sampling, the patchy distribution of CMV, the limited sensitivity of blood-based testing for isolated colonic disease, and the uncertain significance of low-level tissue CMV DNA detected by highly sensitive molecular techniques. We propose a pragmatic testing framework in which immune status informs, but does not alone determine, the threshold for CMV investigation. Disease severity, clinical trajectory, response to initial therapy, and compatible endoscopic features should guide the decision to obtain tissue-based testing. IHC remains central to identifying infected mucosal cells, whilst tissue PCR should be interpreted alongside histopathology, viral burden, and clinical context rather than used alone to establish disease. A severity- and trajectory-guided approach may improve recognition of clinically significant CMV involvement whilst reducing both inappropriate escalation of immunosuppression in unrecognised CMV disease and unnecessary antiviral treatment of low-level viral reactivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Darlington Memorial Hospital, County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom.
- Division of Gastroenterology and Hepatology, The Medical City for Military and Security Services, Muscat, Oman.
- School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Zitieren
APA
Khan, M. A., Taifour, R., & Al-Dury, S. (2026). Cytomegalovirus in severe colitis: diagnostic pitfalls and a pragmatic testing framework. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1813808
Vancouver
Khan MA, Taifour R, Al-Dury S. Cytomegalovirus in severe colitis: diagnostic pitfalls and a pragmatic testing framework. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1813808
BibTeX
@article{Khan2026,
author = {Khan, Mohammed Adnan and Taifour, Rima and Al-Dury, Samer},
title = {Cytomegalovirus in severe colitis: diagnostic pitfalls and a pragmatic testing framework},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1813808}
}
EUVIMED